GenomeWeb’s 360Dx Highlights CE Mark Approval of ORTHO CONNECT™ V2.0 Middleware Solution

GenomeWeb’s 360Dx Highlights CE Mark Approval of ORTHO CONNECT™ V2.0 Middleware Solution

Jan 12, 2017

GenomeWeb’s 360Dx Highlights CE Mark Approval of ORTHO CONNECT™ V2.0 Middleware Solution

January 12, 2017

ORTHO CONNECT™ strengthens Ortho’s transfusion medicine portfolio capabilities. It was developed to address the myriad demands placed on lab managers, whose limited staff have diverse skill sets and are asked to serve an expanding array of health networks.  

“Ortho is focused on diminishing the complexities of immunohematology testing while improving safety, speed and efficiency throughout the blood bank,” said Robert Yates, Ortho's chief operating officer. “ORTHO CONNECT™ does just that, bringing improved functionality to Laboratory Information Systems that are often relatively rigid and outdated. It’s the perfect complement to our ORTHO VISION® family of analyzers.”

Read the full article
(For best results, view this document in your Google Chrome browser)  
${loading}